Shawn G. Thomas - 19 Feb 2025 Form 4 Insider Report for Atomera Inc (ATOM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Feb 2025, 19:41:31 UTC
Prior SEC filing
31 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ by Mindi Zimmer, as Attorney-in-Fact For: Shawn Thomas

Key filing fact

Shawn G. Thomas filed Form 4 for Atomera Inc (ATOM) on 21 Feb 2025.

Key facts

  • This page summarizes Shawn G. Thomas's Form 4 filing for Atomera Inc (ATOM).
  • 4 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Feb 2025, 19:41.

Change

  • Previous filing in this sequence was filed on 31 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATOM transaction

Common Stock

Award

Transaction value
$0
Shares
+30,064
Change %
Price
$0.000000
Shares after
30,064
Date
19 Feb 2025
Ownership
Direct
Footnotes
F1
ATOM transaction

Common Stock

Award

Transaction value
$0
Shares
+10,021
Change %
+33%
Price
$0.000000
Shares after
40,085
Date
19 Feb 2025
Ownership
Direct
Footnotes
F2
ATOM transaction

Common Stock

Award

Transaction value
$0
Shares
+10,021
Change %
+25%
Price
$0.000000
Shares after
50,106
Date
19 Feb 2025
Ownership
Direct
Footnotes
F3
ATOM transaction

Common Stock

Award

Transaction value
$0
Shares
+10,022
Change %
+20%
Price
$0.000000
Shares after
60,128
Date
19 Feb 2025
Ownership
Direct
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of common stock of which 8.33% shall vest each quarter for the next 36 months commencing on June 1, 2025.

Footnote F2

Each performance stock unit represents a contingent right to receive one share of common stock subject to achieving certain performance criteria. The performance period is January 1, 2025 through December 31, 2025 with vesting on March 1, 2026.

Footnote F3

Each performance stock unit represents a contingent right to receive one share of common stock subject to achieving certain performance criteria. The performance period is January 1, 2025 through December 31, 2026 with vesting on March 1, 2027.

Footnote F4

Each performance stock unit represents a contingent right to receive one share of common stock subject to achieving certain performance criteria. The performance period is January 1, 2025 through December 31, 2027 with vesting on March 1, 2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .